Berlin, April 2023. Alacris Extends ISO15189 Accreditation for NGS Cancer Diagnostics with Illumina and MGI NGS Technologies! We are thrilled to announce that Alacris has taken a great leap forward in molecular cancer diagnostics by extending its ISO15189 accreditation to include both Illumina and MGI NGS technologies.
This exciting development allows us to harness the exceptional power of MGI DNBSEQTM technology, delivering cutting-edge services with outstanding quality, accuracy and flexibility.